Certificate Course in Global Pharmacovigilance

Learn how case triage sorts incoming reports by seriousness and causality, using criteria such as received date and the four minimum criteria: reporter, patient, suspect, product, and adverse event.

Master the four minimum criteria for case validity in pharmacovigilance: identifiable reporter, identifiable patient, suspect product, and adverse event, applicable to reports from patients, physicians, relatives, or authorities.

Learn how to craft a precise case narrative for pharmacovigilance, detailing patient demographics, medical history, concomitant meds, suspect product details, adverse events, actions, and outcomes in chronological order.

Examine how event seriousness is determined for adverse events, covering death, life threatening, hospitalization, disability, congenital anomaly, and medically significant criteria in source documents and safety databases.

Assess causality in pharmacovigilance by evaluating the link between a suspect product and adverse events using UMC causality and ADR probability scales, considering temporal relations, rechallenge, alternatives, and signals.

Explore how product labels—CDSs, Smpc, USP, and IB—guide labeling assessment, safety information, and expedited reporting, including labeled versus unlabeled events and key sections such as warnings, dosing, and pregnancy.

Explore the dechallenge concept in pharmacovigilance by examining how withdrawing a drug tests causality, with dechallenge positive (symptom relief) and dechallenge negative (no relief) outcomes.

Explore the rechallenge concept in pharmacovigilance, defining dechallenge, and detailing positive and negative rechallenge and how restarting a drug after withdrawal helps assess causal links.

Identify CSR sources such as clinical trial, post-marketing, literature, spontaneous, discharge summaries, legal cases, market research, patient support programs, and social media, using source documents to determine reporting origin.

Identify suspected, unexpected, and serious adverse reactions from study drugs in trials. Report within seven days if fatal or life-threatening, otherwise within fifteen days for other serious outcomes.

Explore special situation scenarios in pharmacovigilance, including non standard conditions like drug abuse, misuse, off label use, medication errors, overdose, pregnancy, and breastfeeding, for compliant reporting and risk assessment.

Explore the key regulatory authorities worldwide that enforce rules for drug development, licensing, registration, manufacturing, marketing, and labeling in pharmacovigilance, with examples like the FDA, MHRA, and EMA.

Learn how to submit pharmacovigilance cases to regulatory authorities, with timelines by seriousness: death or life threatening within 7 days, serious within 15 days, non-serious within 90 days.

Learn MedDRA, the regulatory medical dictionary, its hierarchy from alt to PT to HLT and HLG, and how updates and SMCs aid adverse event coding and signal detection.

Explore the who drug dictionary and its company, suspect/concomitant, and herbal dictionaries, learn the 11-character drug codes, and understand the international classification of medicines used in adr reporting.

See how source documents look in pharmacovigilance, using India's adverse event form and the US MedWatch example. Review patient details, history, suspected product, event dates, seriousness, and reporting.

Navigate Argus safety, perform case searches and duplicate checks, and document pharmacovigilance cases across general, patient, product, and narrative tabs, including Metra hierarchy and regulatory reporting.

Learn how to prepare for a pharmacovigilance interview with guidance for freshers and experienced professionals: study pharmacovigilance basics, complete pharmacovigilance project work, note key topics, and research the hiring company.

Master pharmacovigilance job search techniques on LinkedIn and Nokia dot com by keeping a 100% complete profile, networking for referrals, and using company career pages and walk-in interviews.

Pharmacovigilance offers a white-collar corporate role in MNCs, strong compensation and benefits, flexible work options, and growing opportunities in patient safety worldwide.

retrieve your completion certificate from your profile, share on LinkedIn, access downloadable resources, and explore advanced pharmacovigilance courses—from signal detection to AI in pharmacovigilance and regulatory affairs.